1. Home
  2. RGP vs MSLE Comparison

RGP vs MSLE Comparison

Compare RGP & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$4.71

Market Cap

138.0M

ML Signal

HOLD

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$5.88

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RGP
MSLE
Founded
1996
N/A
Country
United States
Canada
Employees
N/A
17
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
138.0M
146.9M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
RGP
MSLE
Price
$4.71
$5.88
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
313.6K
26.6K
Earning Date
04-08-2026
N/A
Dividend Yield
6.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$551,331,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$5.50
52 Week High
$6.07
$13.39

Technical Indicators

Market Signals
Indicator
RGP
MSLE
Relative Strength Index (RSI) 61.95 39.16
Support Level $4.21 $5.50
Resistance Level $4.82 $8.59
Average True Range (ATR) 0.22 0.45
MACD 0.01 -0.09
Stochastic Oscillator 89.92 16.30

Price Performance

Historical Comparison
RGP
MSLE

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: